Investigating how stress in thyroid cells leads to cell death
Endoplasmic Reticulum stress and thyroid cell death
This study is looking at how stress in thyroid cells, caused by certain gene mutations, can lead to cell death and affect thyroid hormone production, helping us understand thyroid problems better and possibly find new treatments for patients.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Michigan at Ann Arbor NIH-funded |
| Lab location | 1 site (Ann Arbor, United States) |
| Project ID | NIH-11073096 on NIH RePORTER |
What this research studies
This research focuses on understanding the relationship between endoplasmic reticulum (ER) stress and the death of thyroid cells, which is crucial for the production of the thyroid hormone thyroxine (T4). The study examines how mutations in the thyroglobulin (TG) gene can cause misfolded proteins that accumulate in the ER, leading to cellular stress and ultimately cell death. By exploring these mechanisms, the research aims to uncover whether this cell death is a common occurrence in individuals with certain genetic mutations related to thyroid function. Patients may benefit from insights into the underlying causes of thyroid-related disorders and potential new treatment strategies.
Who could benefit from this research
Good fit: Ideal candidates for this research include individuals with congenital hypothyroidism or those who are carriers of mutations in the TG gene.
Not a fit: Patients without any genetic predisposition to thyroid disorders or those with unrelated health issues may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved understanding and treatment options for patients with thyroid disorders, particularly those related to genetic mutations.
How similar studies have performed: Previous research has shown that understanding protein misfolding and ER stress can lead to significant advancements in treating related conditions, suggesting that this approach has potential for success.
Where this research is happening
Ann Arbor, United States
- University of Michigan at Ann Arbor — Ann Arbor, United States (Active)
Researchers
- Principal investigator: Arvan, Peter — University of Michigan at Ann Arbor
- Study coordinator: Arvan, Peter
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.